| Literature DB >> 20429886 |
Daren K Heyland1, Naomi E Cahill, Rupinder Dhaliwal, Miao Wang, Andrew G Day, Ahmed Alenzi, Fiona Aris, John Muscedere, John W Drover, Stephen A McClave.
Abstract
INTRODUCTION: The purpose of this pilot study is to assess the feasibility, acceptability, and safety of a new feeding protocol designed to enhance the delivery of enteral nutrition (EN).Entities:
Mesh:
Substances:
Year: 2010 PMID: 20429886 PMCID: PMC2887201 DOI: 10.1186/cc8991
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Patient characteristics and clinical outcomes
| Before | After | ||
|---|---|---|---|
| 0.39 | |||
| Mean ± SD | 59.5 ± 17.3 | 64.4 ± 16.7 | |
| 1.0 | |||
| Female | 9 (45.0%) | 13 (43.3%) | |
| Male | 11 (55.0%) | 17 (56.7%) | |
| 0.86 | |||
| Medical | 16 (80.0%) | 22 (73.3%) | |
| Surgical: Elective | 3 (15.0%) | 7 (23.3%) | |
| Surgical: Emergency | 1 (5.0%) | 1 (3.3%) | |
| 0.07 | |||
| Cardiovascular/vascular | 7 (35.0%) | 7 (23.3%) | |
| Respiratory | 3 (15.0%) | 8 (26.7%) | |
| Gastrointestinal | 0 | 5 (16.7%) | |
| Neurologic | 1 (5.0%) | 2 (6.7%) | |
| Sepsis | 5 (25.0%) | 1 (3.3%) | |
| Trauma | 3 (15.0%) | 1 (3.3%) | |
| Metabolic | 0 | 2 (6.7%) | |
| Renal | 0 | 2 (6.7%) | |
| Other | 1 (5.0%) | 2 (6.7%) | |
| 0.73 | |||
| Mean ± SD | 20.7 ± 6.9 | 21.3 ± 7.3 | |
| 1.0 | |||
| No | 20 (100.0%) | 29 (96.7%) | |
| Yes | 0 | 1 (3.3%) | |
| 0.14 | |||
| Median(IQR) | 17.9 (11.2 to 47.8) | 8.5 (4.9 to 12.7) | |
| 0.02 | |||
| Median (IQR) | 57.4 (36.3 to Und.‡) | 22.9 (18.0 to 46.6) | |
| 0.06 | |||
| Median(IQR) | 11.8 (7.6 to 43.3) | 5.8 (3.6 to 8.6) | |
| 0.16 | |||
| No | 18 (90.0%) | 21 (70.0%) | |
| Yes | 2 (10.0%) | 9 (30.0%) | |
* Age and Apache II score were tested by the Wilcoxon-Mann-Whitney test, categorical variables were tested by Fisher's exact test, and length of stay variables were tested by the log-rank test.
† Based on 60-day survivors only. Time before ICU admission is not counted.
‡ Undefined because 44% (8/18) of surviving patients remained in hospital 60 days after ICU admission.
SD, standard deviation; IQR, interquartile range; APACHE, acute physiology and chronic health evaluation score; ARDS, acute respiratory distress syndrome; ICU, intensive care unit.
Patient nutrition assessment information
| Before | After | ||
|---|---|---|---|
| 0.34 | |||
| Mean ± SD | 1.7 ± 0.1 | 1.7 ± 0.1 | |
| 0.92 | |||
| Mean ± SD | 79.3 ± 26.8 | 81.8 ± 27.3 | |
| 0.75 | |||
| Mean ± SD | 26.9 ± 6.7 | 29.5 ± 11.2 | |
| 0.001 | |||
| Actual Body Weight (ABW) | 10 (50.0%) | 21 (70.0%) | |
| Estimated | 7 (35.0%) | 5(16.7%) | |
| Adjusted by 25% (ABW × 0.25 + Ideal body weight) | 1 (5.0%) | 4 (13.3%) | |
| No assessment completed | 1 (5.0%) | 0 | |
| Other, please specify | 1 (5.0%) | 0 | |
| 0.29 | |||
| Ireton-Jones Equation | 17 (85.0%) | 29 (96.7%) | |
| Weight based: 30-35 Kcal/Kg | 1 (5.0%) | 1 (3.3%) | |
| Other, please specify | 2 (10.0%) | 0 | |
| 0.19 | |||
| Mean ± SD | 1983.8 ± 504.1 | 1831.2 ± 293.3 | |
| 0.29 | |||
| Mean ± SD | 88.6 ± 20.2 | 83.2 ± 13.4 | |
| 0.18 | |||
| Mean ± SD | 26.4 ± 6.6 | 24.0 ± 5.9 | |
| 0.13 | |||
| Mean ± SD | 1.2 ± 0.4 | 1.1 ± 0.2 | |
Variable pertinent to the nutritional assessment of study patients. SD, standard deviation; ABW, actual body weight; IBW, Ideal body weight
Nutritional outcomes
| Before | After | ||
|---|---|---|---|
| 0.23 | |||
| Mean ± SD | 71.7% ± 32.5% | 80.3% ± 27.0% | |
| 0.13 | |||
| Mean ± SD | 61.2% ± 29.3% | 73.6% ± 28.6% | |
| 0.23 | |||
| Mean ± SD | 58.8% ± 31.4% | 70.2% ± 26.3% | |
| 0.08 | |||
| Mean ± SD | 61.2% ± 29.3% | 76.1% ± 25.5% | |
| 0.16 | |||
| EN only | 18 (90.0%) | 29 (96.7%) | |
| PN only | 0 | 1 (3.3%) | |
| EN + PN | 2 (10.0%) | 0 | |
| 0.96 | |||
| Prior to ICU admission | 1 (5.0%) | 2 (7.1%) | |
| 0 to 24 | 15 (75.0%) | 21 (75.0%) | |
| >24 to 48 | 4 (20.0%) | 3 (10.7%) | |
| >48 to 72 | 0 | 1 (3.6%) | |
| >72 | 0 | 1 (3.6%) | |
| 0.72 | |||
| Mean ± SD | 16.0 ± 13.8 | 17.7 ± 16.9 | |
| 0.70 | |||
| n/N (%) | 78/192 (40.6%) | 104/243 (42.8%) | |
| 0.11 | |||
| n/N (%) | 11/20 (55.0%) | 24/30 (80%) | |
| 0.03 | |||
| n/N (%) | 0 | 7/30 (23.3%) | |
| 0.08 | |||
| n/N (%) | 7/20 (35.0%) | 19/30 (63.3%) | |
| 0.007 | |||
| n/N (%) | 0 | 9/30 (30.0%) | |
| 1.0 | |||
| mean ± SD | 8.0 ± 0.9 | 8.1 ± 1.0 | |
| 0.60 | |||
| mean ± SD | 16.4% ± 10.1% | 16.2% ± 12.8% | |
† includes propofol, EN, and PN when there is a contraindication for EN
‡ includes the first seven ICU days only
¶ The average duration of use of motility agents is 5.9 days in the after group.
£ The average duration of use of supplemental protein is four days in the after group.
SD, standard deviation; EN, enteral nutrition; PN, parenteral nutrition; ICU, intensive care unit
Figure 1Adequacy of calories and proteins from EN. (a) Amount of calories received over the amount prescribed during the first seven days between the two study groups. (b) Amount of protein received over the amount prescribed during the first seven days between the two study groups.
Figure 2Adequacy of calories and proteins from EN (before group vs. after group on full volume feeds). (a) Amount of calories received over the amount prescribed during the first seven days in patients in before group compared to those on full volume feeds in the after group. (b) Amount of protein received over the amount prescribed during the first seven days in patients in before group compared to those on full volume feeds in the after group.
Complications
| Before | After | ||
|---|---|---|---|
| 0.38 | |||
| No | 17 (85%) | 28 (93.3%) | |
| Yes | 3 (15%) | 2 (6.7%) | |
| 0.16 | |||
| No | 18 (90%) | 30 (100%) | |
| Yes | 2 (10%) | 0 | |
| 0.16 | |||
| No | 18 (90%) | 30 (100%) | |
| Yes | 2 (10%) | 0 | |
| 0.45 | |||
| No | 15 (75%) | 26 (86.7%) | |
| Yes | 5 (25%) | 4 (13.3%) | |
ICU, intensive care unit